Journal articleDermatol Online J2020
A novel CDKN2A in-frame deletion associated with pancreatic cancer-melanoma syndrome.
- Journal
- Dermatol Online J
- Published
- 15 August 2020
- Citations
- 1
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic cancer-melanoma syndrome (PCMS) is an inherited condition in which mutation carriers have an increased risk of malignant melanoma and/or pancreatic cancer. About 30% of PCMS cases carry mutations in CDKN2A. … Excerpt only: this text is the publisher’s. Read it in full at the source.